Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 18, 2025
Factor XI inhibitors and atrial fibrillation: imminent breakthrough or false start?Carmelo Raffo, Giacinto Di Leo, Davide Capodanno
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Early discontinuation of acetylsalicylic acid after angioplasty in acute coronary syndromes: the NEO-MINDSET and TARGET-FIRST studiesGiacinto Di Leo, Diego Nastasi, Davide Capodanno
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 17, 2026
Antithrombotic therapy for cancer-associated venous thromboembolismGiacinto Di Leo, Costanza Agata Bordonaro, Davide Capodanno
Expert Review of Medical Devices|February 27, 2025
Expanding indications for drug-coated balloons in coronary artery diseaseAntonio Greco, Giacinto Di Leo, Marco Spagnolo, et al.
European Heart Journal. Acute Cardiovascular Care|January 5, 2026
Dual Antiplatelet Therapy Escalation and De-escalationAntonio Greco, Giacinto Di Leo, Simone Finocchiaro, et al.
Journal of Clinical Medicine|June 12, 2026
Antithrombotic Therapy in Primary and Secondary Prevention of Coronary Artery DiseaseGiacinto Di Leo, Marco Spagnolo, Daniele Giacoppo, et al.
Heart (British Cardiac Society)|March 18, 2026
Post-acute coronary syndrome cardiovascular rehabilitation: insights into endpoints, biomarkers and clinical practiceLuigi Cutore, Denise Cristiana Faro, Carmelo Raffo, et al.
Journal of the American Heart Association|April 9, 2026
From Caging to Uncaging With Bioadaptors: A Novel Paradigm in Coronary RevascularizationPlacido Maria Mazzone, Marco Spagnolo, Simone Finocchiaro, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 18, 2025
Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysisMarco Spagnolo, Claudio Laudani, Antonino Imbesi, et al.
European Heart Journal|June 5, 2026
P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysisMarco Spagnolo, Antonino Imbesi, Costanza Agata Bordonaro, et al.
Pageof 2